Skip to content
healthcare.dev

BUPROPION HYDROCHLORIDE

NDC 59651-874, BUPROPION HYDROCHLORIDE, tablet, film coated, from Aurobindo Pharma Limited.

Product NDC
59651-874
Status
Listed
Labeler
Aurobindo Pharma Limited
Dosage form
TABLET, FILM COATED
Route
ORAL
Product type
HUMAN PRESCRIPTION DRUG
Marketing category
ANDA
Application
ANDA075491
DEA schedule
None
Request
curl https://api.healthcare.dev/v1/drugs/ndc/59651-874 \
  -H "Authorization: Bearer $HDEV_API_KEY"

Product

Active ingredients and packages

Active ingredients

  • BUPROPION HYDROCHLORIDE75 mg/1

Pharmacologic classes

Aminoketone [EPC]; Dopamine Uptake Inhibitors [MoA]; Increased Dopamine Activity [PE]; Increased Norepinephrine Activity [PE]; Norepinephrine Uptake Inhibitors [MoA]

Package NDCNDC-11Package
59651-874-0159651087401100 TABLET, FILM COATED in 1 BOTTLE (59651-874-01)

Linked data

RxNorm, label and prices

RxNorm concepts

Related lookups

  • FDA label sections

    GET /v1/drugs/labels/6563b923-269f-40c3-b992-cbacdfca6e16
  • NADAC price for package 59651087401

    GET /v1/drugs/nadac/59651087401

Use it

Look up 59651-874 from code or an agent

curl
curl https://api.healthcare.dev/v1/drugs/ndc/59651-874 \
  -H "Authorization: Bearer $HDEV_API_KEY"
MCP prompt
Using the healthcare.dev MCP server, look up NDC 59651-874. Tell me the product, its labeler, dosage form and route, its packages, and the RxNorm concepts it maps to.

Source: FDA, release 2026-10-23. Public domain. Reference data, not medical advice.